IL6 and COVID-19: IL-6 has been linked to CRS severity in multiple studies and surpassed 50 pg ml−1 (research grade measurement) in eight patients (22.2%), levels frequently observed in patients with severe COVID-19 or CAR-T-cell-induced CRS17–19 (Fig. 3d).